TY - JOUR
AU - Holt S.
AU - Wang A.
AU - Johnson D.
AU - Jha V.
AU - Brimble K.
AU - Brunier G.
AU - Kang S.
AU - Kooman J.
AU - Lambie M.
AU - McIntyre C.
AU - Mehrotra R.
AU - Pecoits-Filho R.
AB - <p>
Cardiovascular mortality has remained high in patients on peritoneal dialysis (PD) due to the high prevalence of various cardiovascular complications including coronary artery disease, left ventricular hypertrophy and dysfunction, heart failure, arrhythmia (especially atrial fibrillation), cerebrovascular disease, and peripheral arterial disease. In addition, nearly a quarter of PD patients develop sudden cardiac death as the terminal life event. Thus, it is essential to identify effective treatment that may lower cardiovascular mortality and improve survival of PD patients. The International Society for Peritoneal Dialysis (ISPD) commissioned a global workgroup in 2012 to formulate a series of recommendation statements regarding lifestyle modification, assessment and management of various cardiovascular risk factors, and management of the various cardiovascular complications to be published in 2 guideline documents. This publication forms the second part of the guideline documents and includes recommendation statements on the management of various cardiovascular complications in adult chronic PD patients. The documents are intended to serve as a global clinical practice guideline for clinicians who look after PD patients. We also define areas where evidence is clearly deficient and make suggestions for future research in each specific area.
</p>

AD - Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong aymwang@hkucc.hku.hk.<br/>St. Joseph's Healthcare, McMaster University, Hamilton, Ontario, Canada.<br/>Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Ontario, Canada.<br/>Division of Nephrology, The Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia.<br/>George Institute for Global Health India, Postgraduate Institute of Medical Education and Research, Chandigarh, India.<br/>University of Queensland at Princess Alexandra Hospital, Brisbane, Australia Centre for Kidney Disease Research, Translational Research Institute, Brisbane, Australia.<br/>Department of Internal Medicine, College of Medicine, Severance Biomedical Science Institute, Yonsei University, Korea.<br/>Division of Nephrology, University Hospital Maastricht, Maastricht, The Netherlands.<br/>Health Services Research Unit, Institute for Science and Technology in Medicine, Keele University, Keele, Staffordshire, United Kingdom.<br/>School of Medicine, University of Nottingham, Royal Derby Hospital Centre, Derby, United Kingdom.<br/>Harborview Medical Center, Division of Nephrology/Department of Medicine, University of Washington, Washington, DC, United States.<br/>School of Medicine, Pontificia Universidade Catolica do Parana, Curitiba, Parana, Brazil.
AN - 26228783
BT - Peritoneal Dialysis International
DP - NLM
ET - 2015/08/01
J2 - Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
LA - Eng
LB - INDIA
M1 - 4
N1 - Wang, Angela Yee Moon<br/>Brimble, K Scott<br/>Brunier, Gillian<br/>Holt, Stephen G<br/>Jha, Vivekanand<br/>Johnson, David W<br/>Kang, Shin-Wook<br/>Kooman, Jeroen P<br/>Lambie, Mark<br/>McIntyre, Chris<br/>Mehrotra, Rajnish<br/>Pecoits-Filho, Roberto<br/>Perit Dial Int. 2015 7-8;35(4):388-396.
N2 - <p>
Cardiovascular mortality has remained high in patients on peritoneal dialysis (PD) due to the high prevalence of various cardiovascular complications including coronary artery disease, left ventricular hypertrophy and dysfunction, heart failure, arrhythmia (especially atrial fibrillation), cerebrovascular disease, and peripheral arterial disease. In addition, nearly a quarter of PD patients develop sudden cardiac death as the terminal life event. Thus, it is essential to identify effective treatment that may lower cardiovascular mortality and improve survival of PD patients. The International Society for Peritoneal Dialysis (ISPD) commissioned a global workgroup in 2012 to formulate a series of recommendation statements regarding lifestyle modification, assessment and management of various cardiovascular risk factors, and management of the various cardiovascular complications to be published in 2 guideline documents. This publication forms the second part of the guideline documents and includes recommendation statements on the management of various cardiovascular complications in adult chronic PD patients. The documents are intended to serve as a global clinical practice guideline for clinicians who look after PD patients. We also define areas where evidence is clearly deficient and make suggestions for future research in each specific area.
</p>

PY - 2015
SN - 1718-4304 (Electronic)<br/>0896-8608 (Linking)
SP - 388
EP - 396
ST - Perit. Dial. Int.
T2 - Peritoneal Dialysis International
TI - ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part II - Management of Various Cardiovascular Complications
VL - 35
Y2 - FY16
ER -